Abstract: Gastric neuroendocrine tumors（G-NETs） arise in enterochromaffin-like（ECL） cells， which only account for a small part of gastric tumors. People have been less focused on them， so that the diagnosis and treatment of G-NETs are lack of acknowledged guidelines. However， with the increasing incidence， there is more deeply acknowledge in this field. In clinical， G-NETs are compromised of 4 subtypes according to differentiation and the relationship with hypergastrinemia. In the current review， we summarize the pathology， clinical characteristics， which aimed at treatment of it.